Related Experiment Video
Updated: Aug 12, 2026
Biochemical Measurement of Neonatal Hypoxia
Published on: August 24, 2011
Neonatal plasma lipids as measured in cord blood
Insights
Screening neonatal plasma lipids for familial hyperlipoproteinemia (HLP) presents diagnostic challenges. Early diagnosis requires careful follow-up of hyperlipidemic neonates to assess HLP incidence and early detection benefits.
Area of Science:
- Neonatal screening
- Lipid metabolism
- Cardiovascular disease risk factors
Background:
- Familial hyperlipoproteinemia (HLP) diagnosis in neonates is complex.
- Early identification of hyperlipidemia is crucial for potential intervention.
- Neonatal screening of plasma lipids is a key area of research.
Purpose of the Study:
- To review cord blood screening of plasma lipids.
- To highlight challenges in diagnosing familial hyperlipoproteinemia (HLP) in neonates, especially type II.
- To establish reference ranges for neonatal plasma lipids.
Main Methods:
- Analysis of cord blood plasma lipid levels in a cohort of neonates.
- Calculation of mean, standard deviation, and correlation coefficients for cholesterol and triglycerides.
- Definition of upper limits of normal using mean + 2 SD.
Main Results:
- Mean plasma cholesterol: 70.3 +/- 16.9 mg/dl (n=2937).
- Mean triglyceride: 39.6 +/- 19.3 mg/dl (n=1805).
- Mean beta-cholesterol: 34.3 +/- 10.9 mg/dl (n=240) with high correlation to total cholesterol (r=0.89).
- Upper limits of normal: Cholesterol 100 mg/dl, Triglyceride 80 mg/dl, Beta-cholesterol 55 mg/dl.
Conclusions:
- Neonatal plasma lipid screening requires careful interpretation.
- The incidence and value of early HLP diagnosis depend on diligent follow-up of affected infants.
- Further research is needed to refine diagnostic criteria and assess long-term outcomes.
Abstract:
The status of cord blood screening of plasma lipids is reviewed, emphasizing the problems associated with the diagnosis of familial hyperlipoproteinemia (HLP), particularly type II (hyperbetalipoproteinemia), in the neonate. For 2937 neonates in this study the mean +/- standard deviation (SD) of plasma cholesterol was 70.3 +/- 16.9 mg/dl. The mean triglyceride level of 1805 neonates was 39.6 +/- 19.3 mg/dl. The mean level of beta-cholesterol in 240 neonates was 34.3 +/- 10.9 mg/dl and the correlation between total and beta-cholesterol was high (r=0.89). By convention, the upper limit of normal was defined as the mean + 2 SD, and these levels for total cholesterol, triglyceride and beta-cholesterol were 100, 80 and 55 mg/dl respectively. Only by careful follow-up of hyperlipidemic neonates can the incidence of HLP and the worth of early diagnosis be assessed.
